DAWA Genetics Laboratory

You can now order the Genomind Professional PGX test at DAWA Genetics Laboratory in Poland

DAWA Genetics Laboratory provides official access to the Genomind Professional PGx Test — a clinically validated pharmacogenetic test designed to support safer and more effective personalized therapy for mental health and neurological conditions. The test is available for ordering for clinics and patients in Poland, Ukraine, and Central Asia.

Learn about the Genomind Professional PGx Test

DAWA Genetics Laboratory serves test performance and supports patients, clinics, and specialists in test ordering, provides kits for buccal swab collection, organizes logistics, documentation, and information support throughout the entire testing process.

What Is the Genomind Professional PGx Test
The Genomind Professional PGx Test is designed to support treatment decisions in mental health and neurology, helping clinicians reduce the risk of adverse drug events and improve therapy outcomes. It is a pharmacogenetic test that analyzes clinically relevant genetic variants to understand how an individual’s genetics may influence medication tolerability, metabolism, and response.
Read More

Genetics →
Identifies specific genetic variants that may be associated with variability in medication metabolism, tolerability, and response.
Drug Response →
Associates genetic markers with potential variability in drug exposure and response, based on available clinical and scientific evidence.
Informed Therapy Decisions
Provides pharmacogenetic information intended to support clinical decision-making and complement, not replace, clinician judgment.

Clinical Areas Covered

Mental Health:

- Depression
- Anxiety Disorders
- Bipolar Disorder
- OCD
- PTSD

Neurology & Chronic Pain:

- Migraine
- Fibromyalgia
- Chronic Pain Syndromes

The test provides actionable insights that may support safer medication selection and dosing based on established clinical guidelines.

How Test Results May Support Personalized Therapy

Genetic variability can significantly affect how medications are metabolized and tolerated. The Genomind Professional PGx Test provides clinicians with genetic information that may help:
– Identify medications with increased risk of adverse effects
– Highlight medications requiring dose adjustments
– Support safer prescribing decisions aligned with CPIC, DPWG, and FDA guidance

Important note:
Pharmacogenetic testing is intended to complement — not replace — clinical judgment and comprehensive medical assessment.

Ordering and Logistics
Support in Poland
DAWA Genetics provides comprehensive organizational support for ordering the Genomind Professional PGx Test, including documentation handling, secure logistics, and coordination of testing performed in a laboratory using technologies developed in the United States.
How to Order the Test

Requisition →
Your healthcare provider completes the test order, confirming your information and selecting the genetic analysis relevant to your care.
Kit →
You receive a collection kit with clear instructions to provide a sample that will be sent to the laboratory for analysis.
Lab →
The laboratory examines your sample to identify specific genetic variants using established and quality-controlled methods.
Report
The report summarizes identified genetic variants and information your clinician may consider when reviewing treatment options.